Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli
- PMID: 25834712
- PMCID: PMC4377167
- DOI: 10.5812/jjm.17744
Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli
Abstract
Background: Bacteriophages are viruses that attack bacteria and lead to their lysis in an efficient and highly specific manner. These natural enemies of bacteria were used as therapeutic agents before the advent of antibiotics. Currently, with the rapid spread of multi-drug resistant bacteria, phage therapy can be an effective alternative treatment for antibiotic resistant bacteria.
Objectives: This study evaluated the effectiveness of bacteriophages in removing antibiotic-resistant clinical Escherichia coli strains in vitro and in vivo.
Patients and methods: Different samples were taken from bed sore and foot ulcers of patients with diabetes. E. coli strains were isolated and identified by standard methods. The antibiogram was ascertained using the Kirby Bauer disc diffusion method for ten antibiotics. The bacteriophages were isolated from environmental water samples. They were exposed to the host bacteria by the double-layer agar technique (DLA) to observe plaques. Cross reaction of the phages on test E. coli strains was performed to determine broader-spectrum phages. Phage TPR7 was selected for animal trials. Five groups of mice including a control group, bacterial group, phage group, antibiotic therapy group and phage therapy group, were examined.
Results: Ten E. coli strains were isolated from hospital samples. They showed high resistance to the used antibiotics. An effective bacteriophage was isolated for each strain. The cross-reaction showed phages which affect more than six E. coli strains. They can be a good choice for clinical therapeutic use. In animal trials the group challenged with phages after being infected showed similar results as the group treated with gentamicin after being infected. In both groups infection was removed after 48 hours.
Conclusions: According to the results, six strains were resistant to six or seven antibiotics and all strains were at least resistant to two antibiotics. However, for each of these resistant bacteria one bacteriophage was isolated from environmental samples, which showed the effectiveness of bacteriophages to remove clinically resistant E. coli strains. Effective phages in vitro showed effective results in vivo as well.
Keywords: Antibiotic Resistant; Bacteriophage; Hospital; Mice.
Figures
Similar articles
-
[Biological characteristics and genomic information of a bacteriophage against pan-drug resistant Klebsiella pneumoniae in a burn patient and its effects on bacterial biofilm].Zhonghua Shao Shang Za Zhi. 2020 Jan 20;36(1):14-23. doi: 10.3760/cma.j.issn.1009-2587.2020.01.004. Zhonghua Shao Shang Za Zhi. 2020. PMID: 32023713 Chinese.
-
Characterization of Lytic Bacteriophages Infecting Multidrug-Resistant Shiga Toxigenic Atypical Escherichia coli O177 Strains Isolated From Cattle Feces.Front Public Health. 2019 Nov 26;7:355. doi: 10.3389/fpubh.2019.00355. eCollection 2019. Front Public Health. 2019. PMID: 32039126 Free PMC article.
-
The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.BMC Microbiol. 2018 Aug 31;18(1):97. doi: 10.1186/s12866-018-1234-4. BMC Microbiol. 2018. PMID: 30170558 Free PMC article.
-
Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.Curr Drug Deliv. 2016;13(3):309-23. doi: 10.2174/156720181303160520193946. Curr Drug Deliv. 2016. PMID: 27090515 Review.
-
Phage therapy--constraints and possibilities.Ups J Med Sci. 2014 May;119(2):192-8. doi: 10.3109/03009734.2014.902878. Epub 2014 Mar 30. Ups J Med Sci. 2014. PMID: 24678769 Free PMC article. Review.
Cited by
-
Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans.Pathog Immun. 2022 Oct 17;7(2):1-45. doi: 10.20411/pai.v7i2.516. eCollection 2022. Pathog Immun. 2022. PMID: 36320594 Free PMC article. Review.
-
Three New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage Therapy.PLoS One. 2016 Jun 9;11(6):e0156773. doi: 10.1371/journal.pone.0156773. eCollection 2016. PLoS One. 2016. PMID: 27280590 Free PMC article.
-
A Review of Phage Therapy against Bacterial Pathogens of Aquatic and Terrestrial Organisms.Viruses. 2017 Mar 18;9(3):50. doi: 10.3390/v9030050. Viruses. 2017. PMID: 28335451 Free PMC article. Review.
-
Sequential Combined Effect of Phages and Antibiotics on the Inactivation of Escherichia coli.Microorganisms. 2018 Dec 5;6(4):125. doi: 10.3390/microorganisms6040125. Microorganisms. 2018. PMID: 30563133 Free PMC article.
-
Isolation, Characterization, and Complete Genome Sequence of Escherichia Phage KIT06 Which Infects Nalidixic Acid-Resistant Escherichia coli.Antibiotics (Basel). 2024 Jun 23;13(7):581. doi: 10.3390/antibiotics13070581. Antibiotics (Basel). 2024. PMID: 39061264 Free PMC article.
References
-
- Sulakvelidze A. The challenges of bacteriophage therapy. Eur Ind Pharm. 2011;10:14–8.
-
- Abhilash M, Vidya A, Jagadevi T. Bacteriophage therapy: A war against antibiotic resistant bacteria. Internet J Altern Med. 2009;7(1):e17744
-
- Alexander SK, Strete D, Niles MJ. Laboratory exercises in organismal and molecular microbiology. McGraw-Hill; 2004.
LinkOut - more resources
Full Text Sources
Other Literature Sources